Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Compérat

Showing results (221-230 of 243) with videos related to

Pageof 25
Sort By:
European Urology|March 21, 2025
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 GuidelinesAntoine G van der Heijden, Harman Max Bruins, Albert Carrion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2022
An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell CarcinomasXiaofan Lu, Yann Vano, Alexandra Helleux, et al.
European Urology|March 21, 2025
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 UpdateAlexandra Masson-Lecomte, Alison Birtle, Benjamin Pradere, et al.
European Urology|October 20, 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
European Urology|April 25, 2022
Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysisPawel Rajwa, Benjamin Pradere, Giorgio Gandaglia, et al.
European Urology Oncology|May 12, 2026
Neoadjuvant Intravesical Therapy for Patients with Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysisPaolo Zaurito, Pietro Scilipoti, Alfonso Santangelo, et al.
European Urology|March 16, 2024
Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31]J Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
The Journal of Urology|October 29, 2024
Long-Term Recurrence Risk, Metastatic Potential, and Length of Cystoscopic Surveillance of Low-Grade Nonmuscle-Invasive Bladder CancerEunice Villegas, Katherine Lajkosz, Shayan Din, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2023
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer GroupAshish M Kamat, Andrea B Apolo, Marek Babjuk, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 9, 2022
Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomySatoshi Katayama, Benjamin Pradere, Nico C Grossman, et al.
Pageof 25

Showing results (221-230 of 243) with videos related to

Sort By:
Pageof 25
European Urology|March 21, 2025
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 GuidelinesAntoine G van der Heijden, Harman Max Bruins, Albert Carrion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2022
An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell CarcinomasXiaofan Lu, Yann Vano, Alexandra Helleux, et al.
European Urology|March 21, 2025
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 UpdateAlexandra Masson-Lecomte, Alison Birtle, Benjamin Pradere, et al.
European Urology|October 20, 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
European Urology|April 25, 2022
Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysisPawel Rajwa, Benjamin Pradere, Giorgio Gandaglia, et al.
European Urology Oncology|May 12, 2026
Neoadjuvant Intravesical Therapy for Patients with Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysisPaolo Zaurito, Pietro Scilipoti, Alfonso Santangelo, et al.
European Urology|March 16, 2024
Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31]J Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
The Journal of Urology|October 29, 2024
Long-Term Recurrence Risk, Metastatic Potential, and Length of Cystoscopic Surveillance of Low-Grade Nonmuscle-Invasive Bladder CancerEunice Villegas, Katherine Lajkosz, Shayan Din, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2023
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer GroupAshish M Kamat, Andrea B Apolo, Marek Babjuk, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 9, 2022
Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomySatoshi Katayama, Benjamin Pradere, Nico C Grossman, et al.
Pageof 25